Announced Mon, 11 May · 23:11 IST
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Compliance View source PDF
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.8%1-day move
₹2212.70
prior close
₹2152.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.0-0.2+0.4-4.8-3.5-3.7-4.1-2.1-1.4-3.3+2.0+11.0—
Up moveDown movePending
AI summary
JB Chemicals & Pharmaceuticals has filed a disclosure with BSE confirming that it does not qualify as a 'Large Corporate' under SEBI's guidelines for debt securities issuance. This filing follows SEBI circular SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023, which sets criteria for entities required to make disclosures related to debt fundraising. The company is proactively clarifying its status to the stock exchange.
Likely market impact
No direct impact on shareholders or stock price. This is a routine regulatory compliance filing that simply confirms the company's classification status under SEBI norms.